Long-Term Assets: The sum of all assets classified as non-current.
Astellas Pharma Inc. (ALPMY) had Long-Term Assets of $14.11B for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$12.62B |
|
$334.93M |
|
$2.30B |
|
$10.32B |
|
$12.35B |
|
$270.85M |
|
$-64.70M |
|
$206.16M |
|
$206.16M |
|
$334.93M |
|
$334.93M |
|
$334.93M |
|
$334.93M |
|
$270.85M |
|
$1.59B |
|
1.79B |
|
1.80B |
|
$0.19 |
|
$0.19 |
|
| Balance Sheet Financials | |
$7.93B |
|
$2.17B |
|
|
Long-Term Assets |
$14.11B |
$22.04B |
|
$7.01B |
|
$3.73B |
|
$5.05B |
|
$12.05B |
|
$9.99B |
|
$-169.40M |
|
$9.99B |
|
-- |
|
| Cash Flow Statement Financials | |
$1.28B |
|
$-590.17M |
|
$-1.73B |
|
$2.22B |
|
$1.24B |
|
$-972.28M |
|
-- |
|
$-851.35M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|